(Q38413429)

2 September 2017

title

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study (English)

1 reference

2 September 2017

main subject

anti-retroviral agent

0 references

weight gain

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

C Sabin

4

0 references

Jens Lundgren

11

object named as

J Lundgren

1 reference

Antonella d'Arminio Monforte

2 September 2017

8

object named as

A d'Arminio Monforte

1 reference

2 September 2017

13

D:A:D Study Group

1 reference

2 September 2017

3

P Reiss

1 reference

2 September 2017

5

L Ryom

1 reference

2 September 2017

2

A Mocroft

1 reference

2 September 2017

A C Achhra

1

1 reference

2 September 2017

S de Wit

6

1 reference

2 September 2017

C J Smith

7

1 reference

2 September 2017

A Phillips

9

1 reference

2 September 2017

R Weber

10

1 reference

2 September 2017

M G Law

12

1 reference

2 September 2017

publication date

28 July 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

17

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

255-268

1 reference

HIV infection and obesity: where did all the wasting go?

2 September 2017

cites work

1 reference

High risk of obesity and weight gain for HIV-infected uninsured minorities

21 January 2018

1 reference

HIV infection and obesity: a review of the evidence

21 January 2018

1 reference

Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

21 January 2018

1 reference

Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons

21 January 2018

1 reference

Changes in metabolic syndrome status after initiation of antiretroviral therapy

21 January 2018

1 reference

HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function

21 January 2018

1 reference

New insights into the true nature of the obesity paradox and the lower cardiovascular risk

21 January 2018

1 reference

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

21 January 2018

1 reference

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

21 January 2018

1 reference

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts

21 January 2018

1 reference

Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study

21 January 2018

1 reference

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIV.12294

1 reference

2 September 2017

1 reference